Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study

por Tiu, Bruce C, Strohbehn, Ian A, Zhao, Sophia, Ouyang, Tianqi, Hanna, Paul, Wang, Qiyu, Gupta, Shruti, Leaf, David E, Reynolds, Kerry L, Sise, Meghan E
Publicado 2023

Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR

por Hanna, Paul E., Wang, Qiyu, Strohbehn, Ian, Moreno, Daiana, Harden, Destiny, Ouyang, Tianqi, Katz-Agranov, Nurit, Seethapathy, Harish, Reynolds, Kerry L., Gupta, Shruti, Leaf, David E., Sise, Meghan E.
Publicado 2023

Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer

por Hanna, Paul E., Wang, Qiyu, Strohbehn, Ian A., Moreno, Daiana, Harden, Destiny, Ouyang, Tianqi, Katz-Agranov, Nurit, Seethapathy, Harish, Reynolds, Kerry L., Gupta, Shruti, Leaf, David E., Sise, Meghan E.
Publicado 2023

Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer

por Hanna, Paul E., Strohbehn, Ian A., Moreno, Daiana, Harden, Destiny, Seethapathy, Rituvanthikaa, Sawtell, Rani, Wang, Qiyu, Ouyang, Tianqi, Katz-Agranov, Nurit, Dinulos, James, Wander, Seth A., Gupta, Shruti, Sise, Meghan E.
Publicado 2023